Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 176,007 | -81,036 | -59,006 | -42,581 | -20,030 |
| Depreciation Amortization | 75 | 307 | 224 | 145 | 67 |
| Accounts receivable | -882 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -2,277 | 2,334 | -202 | 1,536 | 932 |
| Other Working Capital | -16,503 | 21,819 | 16,433 | 4,169 | 379 |
| Other Operating Activity | 4,479 | 4,992 | 5,477 | 1,126 | 241 |
| Operating Cash Flow | $160,899 | $-51,584 | $-37,075 | $-35,605 | $-18,412 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 35,039 | 35,039 | 35,036 | 4,039 |
| PPE Investments | -12 | -127 | -85 | -67 | -14 |
| Purchase Sale Intangibles | N/A | -263 | -215 | -192 | -189 |
| Other Investing Activity | 0 | -264 | -215 | -192 | -189 |
| Investing Cash Flow | $-12 | $34,648 | $34,739 | $34,777 | $3,836 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 151 | 47,236 | 47,434 | 244 | 83 |
| Other Financing Activity | -21 | -163 | -129 | -59 | -68 |
| Financing Cash Flow | $130 | $47,073 | $47,305 | $185 | $16 |
| Beginning Cash Position | 72,034 | 41,897 | 41,897 | 41,897 | 41,897 |
| End Cash Position | 233,051 | 72,034 | 86,866 | 41,254 | 27,337 |
| Net Cash Flow | $161,017 | $30,137 | $44,969 | $-643 | $-14,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | 160,899 | -51,584 | -37,075 | -35,605 | -18,412 |
| Capital Expenditure | -12 | -127 | -85 | -67 | -14 |
| Free Cash Flow | 160,888 | -51,711 | -37,160 | -35,672 | -18,426 |